News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,039 Results
Type
Article (8033)
Company Profile (140)
Press Release (476769)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166746)
Career Advice (304)
Deals (25740)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238203)
Policy (17901)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33163)
ALS (105)
Alzheimer's disease (978)
Antibody-drug conjugate (ADC) (270)
Approvals (10388)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (206)
Automation (28)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (110)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (512)
Cancer (3672)
Cardiovascular disease (221)
Career advice (246)
Career pathing (1)
CAR-T (174)
CDMO (7)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47910)
Collaboration (1252)
Commercialization (3)
Compensation (1473)
Complete response letters (34)
COVID-19 (758)
CRISPR (63)
C-suite (757)
Cystic fibrosis (85)
Data (5694)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (346)
Diagnostics (4191)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73726)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87689)
Executive appointments (703)
FDA (12420)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (925)
Gene editing (125)
Generative AI (9)
Gene therapy (319)
GLP-1 (292)
Government (953)
Grass and pollen (2)
Guidances (281)
Healthcare (9337)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (57)
Indications (157)
Infectious disease (946)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (258)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5210)
Licensing (10)
Liver cancer (44)
Longevity (18)
Lung cancer (511)
Lymphoma (253)
Machine learning (27)
Management (3)
Manufacturing (537)
Marketing (8)
MASH (118)
Medical device (8662)
Medtech (8809)
Mergers & acquisitions (14391)
Metabolic disorders (718)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1833)
NextGen: Class of 2026 (3155)
Non-profit (847)
Obesity (230)
Opinion (12)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (200)
Parkinson's disease (201)
Partnered (12)
Patents (479)
Patient recruitment (512)
Peanut (31)
People (41272)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15475)
Phase 2 (21392)
Phase 3 (14419)
Pipeline (7417)
Policy (18)
Postmarket research (1573)
Preclinical (6540)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (576)
Real estate (3021)
Recruiting (6)
Regulatory (14868)
Reports (21)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (156)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Special edition (1)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (50)
Vaccines (330)
Venture capital (17)
Weight loss (78)
Women's health (81)
Date
Today (20)
Last 7 days (241)
Last 30 days (1543)
Last 365 days (18967)
2026 (12541)
2025 (19257)
2024 (22994)
2023 (26540)
2022 (34588)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17470)
2017 (18767)
2016 (17919)
2015 (24263)
2014 (21680)
2013 (18139)
2012 (20226)
2011 (20440)
2010 (20332)
Location
Africa (229)
Alabama (74)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17916)
Australia (2102)
California (12048)
Canada (3163)
China (528)
Colorado (486)
Connecticut (413)
Delaware (208)
Europe (24655)
Florida (1801)
Georgia (385)
Hawaii (3)
Idaho (46)
Illinois (706)
India (51)
Indiana (315)
Iowa (15)
Japan (409)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1206)
Massachusetts (7886)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2632)
New Mexico (12)
New York (2826)
North Carolina (1288)
North Dakota (4)
Northern California (6045)
Ohio (280)
Oklahoma (14)
Oregon (18)
Pennsylvania (2262)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (77)
South Dakota (1)
Southern California (5002)
Tennessee (120)
Texas (1955)
United States (39077)
Utah (362)
Vermont (1)
Virginia (155)
Washington D.C. (38)
Washington State (932)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,039 Results for "vivus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
March 25, 2026
·
7 min read
Press Releases
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
March 10, 2026
·
6 min read
Press Releases
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
March 18, 2026
·
8 min read
Press Releases
VIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide
October 9, 2025
·
7 min read
Press Releases
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
·
13 min read
Biotech Bay
VIVUS Provides Update on Pipeline and Program Milestones
VIVUS LLC announced pipeline updates and program milestones.
January 8, 2024
·
12 min read
Press Releases
VIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome (ICOMES)
September 5, 2025
·
7 min read
Press Releases
New Clinical Data Demonstrate that VIVUS’ QSYMIA® in Combination with Digitally Enhanced Lifestyle Interventions (DELI) Leads to Significantly Greater Reductions in Weight and Cardiovascular Risk Compared with DELI Alone in Adults with Obesity
January 27, 2026
·
9 min read
Press Releases
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
March 5, 2025
·
9 min read
Biotech Bay
VIVUS Announces it will Provide Telehealth to Patients through an Enhanced ‘Engage’ Program in Collaboration with UpScriptHealth
VIVUS LLC announced it has entered into a strategic partnership with UpScriptHealth, a leading, nationwide, direct-to-consumer telemedicine company.
April 22, 2024
·
8 min read
1 of 48,504
Next
